Logo
Text

Banner
 

SALIENT FEATURES

Paid patient days (PPDs)

+3.5%
  Group revenue increased to
R7 089 million

+14.1%
  Group normalised EBITDA increased to R1 926 million
+10.8%
Normalised earnings per share from continued operations (excluding funding costs for international acquisitions) increased to 88.9 cents
+10.4%
  Headline earnings per share decreased to 80.3 cents


-2.9%
  Interim dividend: 68 cents per share



+7.9%
 

Commentary

Overview The Group performed well during the first six months of 2015. Southern Africa experienced good activity growth, has a solid pipeline of beds with which to grow the business whilst maintaining EBITDA margins. The Group continued to deliver on its international expansion plans, investing nearly R2 billion in increasing its shareholding in Max and through two acquisitions in Poland. Revenue and EBITDA continued to show good growth in both the Indian and Polish operations. Normalised earnings per share from continued operations,... read more

 

Financial statements

arrow Condensed consolidated statement of comprehensive income
arrow Condensed consolidated statement of financial position
arrow Condensed consolidated statement of changes in equity
arrow Condensed consolidated statement of cash flows
arrow Segmental report
 

Downloads

View booklet [PDF - 112KB]
View presentation [PDF - 2MB]
View english advert [PDF - 52KB]
View afrikaans advert [PDF - 51KB]